[an error occurred while processing this directive]

Hereditas(Beijing) ›› 2026, Vol. 48 ›› Issue (11): 1066-1084.doi: 10.16288/j.yczz.26-109

• Invited Review • Previous Articles     Next Articles

Multi-omics applications in mitochondrial disease research and clinical management

Tianwei Zhou1,2(), Cheng Ai1,2, Minxin Guan1,2()   

  1. 1 Center for Genetic Medicine, International School of Medicine, Zhejiang University, Yiwu 322000, China
    2 Institute of Genetics, Zhejiang University, Hangzhou 310058, China
  • Received:2026-07-03 Revised:2026-08-17 Online:2026-11-20 Published:2026-09-03
  • Contact: Minxin Guan E-mail:22518588@zju.edu.cn;gminxin88@zju.eu.cn
  • Supported by:
    National Natural Science Foundation of China(U25A20134);National Natural Science Foundation of China(32500514)

Abstract:

Mitochondrial diseases are a group of highly heterogeneous genetic disorders that affect any organ at any age, caused by mutations in nuclear and mitochondrial genes, and characterized by complex clinical manifestations and diagnostic challenges. Multi-omics technologies have emerged as essential tools for deciphering the molecular basis of these diseases and improving clinical outcomes. In this review, we summarize the research progress of multi-omics approaches—including genomics, transcriptomics, proteomics, metabolomics, and single-cell sequencing—in resolving genetic and phenotypic heterogeneity and elucidating cell- and tissue-specific mechanisms of representative mitochondrial diseases. We aim to provide a reference and framework for the translation of multi-omics technologies from basic research to clinical application within the field of mitochondrial medicine.

Key words: multi-omics, mitochondrial diseases, mitochondrial DNA, heterogeneous, single-cell sequencing